All Stories

  1. Patients’ and specialist physicians’ perspectives on the use of polygenic risk scores in clinical practice: a cross-sectional study
  2. Assessment of knowledge and professional practices related to dentin hypersensitivity: Results from a practice-based research network (ReCOL) survey
  3. A high-filler-content 3D-printable composite enabled by a novel silanization process bridging the performance gap with milled materials for definitive dental prostheses
  4. Evaluation of statistical methods to study flexural strength of dental CAD-CAM composites
  5. Fatigue behavior of CAD-CAM composites versus lithium disilicate glass-ceramic
  6. The One-step No-prep technique for non-invasive full-mouth rehabilitation of worn dentition using PICN CAD-CAM restorations: Up to 9-year results from a prospective and retrospective clinical study
  7. Do all ceramic and composite CAD-CAM materials exhibit equal bonding properties to implant Ti-base materials? An Interfacial Fracture Toughness Study
  8. A Zebrafish Mutant in the Extracellular Matrix Protein Gene efemp1 as a Model for Spinal Osteoarthritis
  9. Osteomodulin downregulation is associated with osteoarthritis development
  10. Curcuma longa and Boswellia serrata Extracts Modulate Different and Complementary Pathways on Human Chondrocytes In Vitro: Deciphering of a Transcriptomic Study
  11. A multicomponent medicinal product that could improve osteoarthritis.
  12. Osteomodulin impacts positively the bone remodeling process in osteoarthritis
  13. The Damage-Associated Molecular Patterns (DAMPs) as Potential Targets to Treat Osteoarthritis: Perspectives From a Review of the Literature
  14. The secretome of skeletal muscle cells: A systematic review
  15. From Translation to Protein Degradation as Mechanisms for Regulating Biological Functions: A Review on the SLRP Family in Skeletal Tissues
  16. Syndecan-4 Is Increased in Osteoarthritic Knee, but Not Hip or Shoulder, Articular Hypertrophic Chondrocytes
  17. Cross-talk between primary osteocytes and bone marrow macrophages for osteoclastogenesis upon collagen treatment
  18. Comparison of secretome from osteoblasts derived from sclerotic versus non-sclerotic subchondral bone in OA: A pilot study
  19. Fib3-3 as a Biomarker for Osteoarthritis in a Rat Model with Metabolic Dysregulation
  20. Human subchondral osteoblasts cell culture v1
  21. Chondrocyte secretome: a source of novel insights and exploratory biomarkers of osteoarthritis
  22. Étude de l’évolution de la pathologie arthrosique et des propriétés mécaniques du cartilage sur un modèle d’arthrose spontanée chez le cobaye Dunkin-Hartley
  23. Review of Soluble Biomarkers of Osteoarthritis: Lessons From Animal Models
  24. Identification of Targets of a New Nutritional Mixture for Osteoarthritis Management Composed by Curcuminoids Extract, Hydrolyzed Collagen and Green Tea Extract
  25. Osteoarthritis biomarkers derived from cartilage extracellular matrix: Current status and future perspectives
  26. Fibulin-3 fragments are prognostic biomarkers of osteoarthritis incidence in overweight and obese women
  27. Restriction of spontaneous and prednisolone-induced leptin production to dedifferentiated state in human hip OA chondrocytes: role of Smad1 and β-catenin activation
  28. Soluble biomarkers development in osteoarthritis: from discovery to personalized medicine
  29. Carnosol Inhibits Pro-Inflammatory and Catabolic Mediators of Cartilage Breakdown in Human Osteoarthritic Chondrocytes and Mediates Cross-Talk between Subchondral Bone Osteoblasts and Chondrocytes
  30. Chitosan Enriched Three-Dimensional Matrix Reduces Inflammatory and Catabolic Mediators Production by Human Chondrocytes
  31. Curcuminoids Extract, Hydrolyzed Collagen and Green Tea Extract Synergically Inhibit Inflammatory and Catabolic Mediator’s Synthesis by Normal Bovine and Osteoarthritic Human Chondrocytes in Monolayer
  32. Oleuropein or rutin consumption decreases the spontaneous development of osteoarthritis in the Hartley guinea pig
  33. Bone sialoprotein as a potential key factor implicated in the pathophysiology of osteoarthritis
  34. Consequences of chondrocyte hypertrophy on osteoarthritic cartilage: potential effect on angiogenesis
  35. Sirt1-deficient mice exhibit an altered cartilage phenotype
  36. Identification of differential pattern of protein expression in canine osteoarthritis serum after anterior cruciate ligament transection: A proteomic analysis
  37. Sirtuin 1 enzymatic activity is required for cartilage homeostasis in vivo in a mouse model
  38. Epigenetics, sirtuins and osteoarthritis
  39. Subchondral bone and osteoarthritis: biological and cellular aspects
  40. Regulation of subchondral bone osteoblast metabolism by cyclic compression
  41. Increased apoptotic chondrocytes in articular cartilage from adult heterozygous SirT1 mice
  42. Osteochondral plate angiogenesis: A new treatment target in osteoarthritis
  43. La dégénérescence discale est-elle une histoire d’« Os » ?
  44. Néovascularisation de la plaque ostéochondrale : nouvelle cible thérapeutique de l’arthrose
  45. Erratum to “Update in cartilage bio-engineering” [Joint Bone Spine 77 (2010) 283–6]
  46. Chondroitin sulfate in the treatment of osteoarthritis: fromin vitrostudies to clinical recommendations
  47. Bio-ingénierie du cartilage
  48. Update in cartilage bio-engineering
  49. Stigmasterol: a phytosterol with potential anti-osteoarthritic properties
  50. Curcumin inhibits pro-inflammatory mediators and metalloproteinase-3 production by chondrocytes
  51. Mechanical loading highly increases IL-6 production and decreases OPG expression by osteoblasts
  52. Subchondral bone in osteoarthritis physiopathology: State-of-the art and perspectives
  53. Osteoarthritis and obesity: Experimental models
  54. Arthrose et obésité : modèles expérimentaux
  55. Interleukin-1β and interleukin-6 disturb the antioxidant enzyme system in bovine chondrocytes: a possible explanation for oxidative stress generation
  56. Stress-induced signaling pathways in hyalin chondrocytes: inhibition by Avocado–Soybean Unsaponifiables (ASU)
  57. Osteoblast: A cell under compression
  58. Phenotypic characterization of osteoblasts from the sclerotic zones of osteoarthritic subchondral bone
  59. Runx2- and Histone Deacetylase 3-mediated Repression Is Relieved in Differentiating Human Osteoblast Cells to Allow High Bone Sialoprotein Expression
  60. One-year follow-up of Coll2-1, Coll2-1NO2and myeloperoxydase serum levels in osteoarthritis patients after hip or knee replacement
  61. Osteoblasts from the sclerotic subchondral bone downregulate aggrecan but upregulate metalloproteinases expression by chondrocytes. This effect is mimicked by interleukin-6, -1β and oncostatin M pre-treated non-sclerotic osteoblasts
  62. Subchondral bone osteoblasts induce phenotypic changes in human osteoarthritic chondrocytes
  63. Pharmaceutical and nutraceutical management of canine osteoarthritis: Present and future perspectives
  64. Differential regulation of chondrocyte metabolism by oncostatin M and interleukin-6
  65. Effects of rhein on human articular chondrocytes in alginate beads
  66. The inhibition of metalloproteinases to treat osteoarthritis: reality and new perspectives
  67. DataSheet1.zip